Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

plasma kallikrein activity

OBSOLETE. Catalysis of the selective cleavage of Arg-Xaa and Lys-Xaa bonds, including Lys-Arg and Arg-Ser bonds in (human) kininogen to release… Expand
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Kininogenase activity
Plasma Kallikreinurinary kallikrein activity

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes
Plasma kallikrein is the central mediator of the plasma kallikrein–kinin system, which is involved both in vascular control and… Expand
  • figure 1
  • table 1
Is this relevant?
2014
2014
High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
BACKGROUND The inherited deficiency of C1-inhibitor (C1-INH), which can be quantitative (type I) or qualitative (type II), is… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 1
Is this relevant?
2013
2013
Type 2 Diabetes Elicits Lower Nitric Oxide, Bradykinin Concentration and Kallikrein Activity Together with Higher DesArg9-BK and Reduced Post-Exercise Hypotension Compared to Non-Diabetic Condition
This study compared the plasma kallikrein activity (PKA), bradykinin concentration (BK), DesArg9-BK production, nitric oxide… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2010
2010
Effect of type 2 diabetes on plasma kallikrein activity after physical exercise and its relationship to post-exercise hypotension.
AIM The present study was undertaken to determine the effects of type 2 diabetes (T2D) on plasma kallikrein activity (PKA) and… Expand
  • figure 2
Is this relevant?
1998
1998
Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol.
We have examined the preventative effect of nafamostat mesilate, a kallikrein inhibitor, on pain on injection with propofol in a… Expand
  • table 1
Is this relevant?
1997
1997
Disease Severity Is Correlated with Plasma Clotting and Fibrinolytic and Kinin-Kallikrein Activity in Neonatal Respiratory Distress Syndrome
This study was undertaken to determine whether simultaneous activation of clotting, fibrinolysis, and kinin-kallikrein is… Expand
Is this relevant?
1994
1994
Activation of the Plasma Clotting, Fibrinolytic, and Kinin-Kallikrein System in Preterm Infants with Severe Idiopathic Respiratory Distress Syndrome
ABSTRACT: We studied the activation pattern of clotting, fibrinolysis, and kinin-kallikrein during the first 5 d of life in 10… Expand
  • table 1
  • table 2
  • figure I
  • figure 4
  • figure 6
Is this relevant?
1983
1983
Plasma kallikrein activity in human diabetes mellitus.
It has recently been observed that administration of bradykinin to diabetic patients improves peripheral glucose utilization. To… Expand
Is this relevant?
Highly Cited
1982
Highly Cited
1982
Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy.
The effects on the neonate of severe maternal hypertension originating before the thirty-sixth week of gestation were determined… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
Is this relevant?
1978
1978
Increased plasma kallikrein activity and tumour growth suppression associated with intralesional bradykinin injections in hamsters.
Daily intralesional injections of bradykinin (250 microgram) into syngeneic SV40 virus-induced fibrosarcomas in inbred hamsters… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE